Johnson & Johnson (JNJ) financial statements (2022 and earlier)

Company profile

Business Address ONE JOHNSON & JOHNSON PLZ
NEW BRUNSWICK, NJ 08933
State of Incorp. NJ
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments33,49226,66620,43519,68718,29641,90738,376
Cash and cash equivalents14,48713,98517,30518,10717,82418,97213,732
Short-term investments19,00512,6813,1301,58047222,93524,644
Receivables15,28313,57614,48114,09813,49011,69910,734
Inventory, net of allowances, customer advances and progress billings10,3879,3449,0208,5998,7658,1448,053
Inventory10,3879,3449,0208,5998,7658,1448,053
Assets held-for-sale, not part of disposal group  94950   
Other undisclosed current assets1,8171,6511,2442,6992,5373,2823,047
Total current assets:60,97951,23745,27446,03343,08865,03260,210
Noncurrent Assets
Property, plant and equipment18,96218,76617,65817,03517,00515,91215,905
Intangible assets, net (including goodwill)81,63889,79581,28278,06485,13449,68147,393
Goodwill35,24636,39333,63930,45331,90622,80521,629
Intangible assets, net (excluding goodwill)46,39253,40247,64347,61153,22826,87625,764
Deferred income tax assets10,2238,534 
Other noncurrent assets10,2166,5625,6954,1824,9714,4354,413
Defined benefit plan, assets for plan benefits227256
Other undisclosed noncurrent assets  7,8197,6407,1055,9215,234
Total noncurrent assets:121,039123,657112,454106,921114,21576,17673,201
TOTAL ASSETS:182,018174,894157,728152,954157,303141,208133,411
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities29,36528,34923,87919,05419,42116,20015,303
Accounts payable11,0559,5058,5447,5377,3106,9186,668
Accrued liabilities13,61213,9689,7157,6017,3045,6355,411
Employee-related liabilities3,5863,4843,3543,0982,9532,6762,474
Taxes payable1,1121,3922,2668181,854971750
Debt3,8002,6001,2002,8003,9004,7007,000
Other undisclosed current liabilities12,06111,54410,8859,3767,2165,3875,444
Total current liabilities:45,22642,49335,96431,23030,53726,28727,747
Noncurrent Liabilities
Long-term debt and lease obligation29,98532,63526,49427,68430,67522,44212,857
Long-term debt, excluding current maturities29,98532,63526,49427,68430,67522,44212,857
Liabilities, other than long-term debt32,78436,48835,79934,28835,93122,06121,657
Accounts payable and accrued liabilities5,7136,5597,4448,2428,472  
Deferred tax liabilities, net5,9587,5068,3682,9102,562
Deferred income tax liabilities7,4877,214 
Liability, pension and other postretirement and postemployment benefits8,89810,77110,6639,95110,0749,6158,854
Other liabilities10,68611,94411,7348,5899,0179,53610,241
Total noncurrent liabilities:62,76969,12362,29361,97266,60644,50334,514
Total liabilities:107,995111,61698,25793,20297,14370,79062,261
Stockholders' equity
Stockholders' equity attributable to parent74,02363,27859,47159,75260,16070,41871,150
Common stock3,1203,1203,1203,1203,1203,1203,120
Treasury stock, value(39,099)(38,490)(38,417)(34,362)(31,554)(28,352)(22,684)
Accumulated other comprehensive loss(13,058)(15,242)(15,891)(15,222)(13,199)(14,901)(13,165)
Retained earnings123,060113,890110,659106,216101,793110,551103,879
Total stockholders' equity:74,02363,27859,47159,75260,16070,41871,150
TOTAL LIABILITIES AND EQUITY:182,018174,894157,728152,954157,303141,208133,411

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues93,77582,58482,05981,58176,45071,89070,074
Revenue, net76,45071,89070,074
Cost of revenue
(Cost of Goods and Services Sold)
(29,855)(28,427)(27,556)(27,091)(25,354)(21,685)(21,536)
Gross profit:63,92054,15754,50354,49051,09650,20548,538
Operating expenses(40,525)(34,671)(34,689)(34,692)(32,691)(29,560)(30,982)
Operating income:23,39519,48619,81419,79818,40520,64517,556
Nonoperating income (expense)(436)(2,788)(2,168)(794)202(116)2,192
Investment income, nonoperating53111357611385368128
Other nonoperating income (expense)(489)(2,899)(2,525)(1,405)(183)(484)2,064
Interest and debt expense(183)(201)(318)(1,005)(934)(726)(552)
Income from continuing operations before income taxes:22,77616,49717,32817,99917,67319,80319,196
Income tax expense(1,898)(1,783)(2,209)(2,702)(16,373)(3,263)(3,787)
Net income available to common stockholders, basic:20,87814,71415,11915,2971,30016,54015,409
Interest on convertible debt  11123
Net income available to common stockholders, diluted:20,87814,71415,12015,2981,30116,54215,412

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income:20,87814,71415,11915,2971,30016,54015,409
Other comprehensive income (loss)2,184649(669)(1,791)1,702(1,736)(2,443)
Comprehensive income, net of tax, attributable to parent:23,06215,36314,45013,5063,00214,80412,966

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: